Clinical trials
Allergy clinical trials
Below are recruiting allergy clinical trials, each written for real people, not researchers. We’re tracking 322 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07328178Recruiting
Understanding IgE proteins in allergies and immune conditions
This study looks at IgE, a protein involved in allergic reactions, to better understand its role in different immune-related diseases. It aims to find out how different forms of IgE relate to health and disease, which may help improve diagnosis or treatment.
Leuven, Vlaams-BrabantAges 18 years+ - NCT07019389Enrolling by invitation
Food allergy anxiety scale study for Turkish families
This study tests Turkish versions of surveys that measure anxiety about food allergies in children and their parents. It aims to make sure these surveys work well for Turkish-speaking families.
IstanbulAges 8–18 - NCT06916104Enrolling by invitation
Allergies and biotherapy in severe asthma
This study looks at whether having a respiratory allergy affects how well biotherapy works for people with severe asthma. It includes adults already on biotherapy and followed at Poitiers University Hospital.
PoitiersAges 18 years+ - NCT05287074Enrolling by invitation
Checking timing of egg and milk allergy diagnosis in children
This study looks at how quickly children with possible egg and/or milk allergy are correctly diagnosed, and how follow-up checks affect their nutrition and growth. It may help you understand whether timely diagnosis and good monitoring could reduce problems with eating, weight, or growth.
VilniusAges 6 months–12 years - NCT07287033RecruitingPhase 1
Safety study of MY006 in healthy people and people with peanut allergy
This early-phase study tests a new investigational medication (MY006) to see if it is safe and how the body processes it. It is given to both healthy volunteers and people with peanut allergy. The goal is to gather safety information before larger trials.
Little Rock, ArkansasAges 12–55 - NCT07750236Recruiting
Stress ball for easing fear and pain during allergy testing
This trial gives children a stress ball to hold during their allergy skin test, to see if it helps reduce fear, anxiety, and pain, and makes the experience more satisfying for the family.
TarsusAges 4–10 - NCT06673082Enrolling by invitation
Zinc as a new therapy for cow milk allergy in children
This study tests if adding zinc to standard treatment helps children with cow milk protein allergy. It aims to see if zinc can improve their symptoms and make them feel better.
GizaAges 1 month–12 years - NCT06303128RecruitingPhase 3
Testing penicillin allergy with one vs. two oral doses
This trial compares a single dose versus two doses of a penicillin-like drug to see if people who think they are allergic to penicillin can safely be told they are not allergic. It is for people with a low-risk penicillin allergy who want to find out if they can use these antibiotics in the future.
Lubbock, TexasAges 18–89 - NCT06633250Recruiting
Testing a rice-based formula for babies with cow's milk allergy
This trial tests a special formula made from hydrolyzed rice protein in babies with cow's milk protein allergy. The goal is to see if the formula supports healthy growth and is well-tolerated, while also improving quality of life.
BerlinAges Up to 8 months - NCT06771440Recruiting
Tool to safely remove antibiotic allergy labels
This trial tests a tool to help doctors safely remove a beta-lactam antibiotic allergy (like penicillin) from your medical record. If you are in the hospital and have such an allergy listed, this tool may help you get the right treatment.
LeuvenAges 18 years+ - NCT07220811RecruitingPhase 2
Testing a new drug for food allergies
This trial tests a new medication called RPT904 in people with IgE-mediated food allergies to foods like peanut, milk, egg, cashew, or walnut. The goal is to see if it reduces allergic reactions when you eat a small amount of the food.
Phoenix, ArizonaAges 12–55 - NCT06456541Recruiting
Testing a new infant formula for children with cow's milk allergy
This study tests a new formula designed for children diagnosed with cow's milk allergy. It evaluates whether the formula is safe and well-tolerated.
Phoenix, ArizonaAges 3 months–12 years - NCT03539692Recruiting
Screening to join food allergy tests with a food challenge
This study checks whether you’re a safe and willing candidate to take part in food allergy clinical studies at one location. It helps decide who can safely undergo the “gold standard” food challenge to confirm or rule out food allergy.
Palo Alto, CaliforniaAges 1 week–90 years - NCT03539705Recruiting
Food Allergy Registry for People of All Ages
This study is a food allergy registry where you can share your experiences and information. It may help researchers better understand food allergies across different ages.
Palo Alto, CaliforniaAges birth–100 years - NCT03936998RecruitingPhase 1/Phase 2
Study drug for peanut allergy to change immune response
This early-phase study tests VE416, a treatment meant to help reduce peanut allergy reactions by changing how the immune system responds. If you have documented peanut allergy, you may receive the study medicine and, for some people, take part in a supervised peanut “entry challenge.”
Boston, MassachusettsAges 12–55 - NCT07580898RecruitingPhase 1
Testing MOON101 Safety for Peanut Allergy Treatment
This study tests whether a new drug called MOON101 is safe for people with peanut allergies. The goal is to see if it might help your immune system tolerate peanuts better and reduce severe allergic reactions.
Little Rock, ArkansasAges 4–55 - NCT04828603Recruiting
Study of allergies and sensitization in healthy and allergic people
This study looks at how allergies work by comparing people who may have allergies with people who may not. It may help researchers understand what changes happen when the body becomes “sensitized” to triggers like allergens.
Palo Alto, CaliforniaAges 1 week–90 years - NCT05119868Recruiting
Mediterranean diet in pregnancy to prevent baby allergies
This trial studies whether following a Mediterranean-style eating pattern during pregnancy can lower the chance that a child develops allergies. It may help families who already have a higher allergy risk, by changing diet during early pregnancy.
NaplesAges 20–35 - NCT05259826Recruiting
Testing a gut-based IgE blood test for food allergy
This study looks at whether a specific immune signal (IgE) found in the gut lining can help diagnose food allergy or food-related hypersensitivity. You may join if you have symptoms that suggest a food allergy, or (if you’re healthy) if you need endoscopy for other reasons.
ErlangenAges 18 years+ - NCT05521711Recruiting
Testing an at-home route for tree nut allergy immunotherapy
This study tests how a specific form of treatment is given to people with a tree nut allergy. The goal is to find a safer, more effective way to help your body tolerate tree nuts.
Hamilton, OntarioAges 1–16 - NCT05667610Recruiting
Immune and gut diet study for peanut-allergic children
This trial studies whether an immune-supportive diet can improve gut health (gut permeability) in children with confirmed peanut or tree-nut allergy. If you join, the researchers will use allergy testing and gut-related diet approaches to see whether symptoms and gut measures change.
AmsterdamAges 3–17 - NCT05740163Recruiting
Oral treatment to help children with egg allergy
This trial tests an oral (by mouth) immune-based treatment to reduce egg allergy reactions in children ages 6 to 16. It may help some kids become more tolerant to egg, but it requires careful screening and follow-through.
OuluAges 6–16 - NCT05758532RecruitingPhase 4
Modified measles vaccine schedule to help prevent allergies in babies
This study tests whether changing the measles vaccine timing in 6-month-old children can reduce allergy risk and also help protect against unrelated infections. If your child is already up to date with routine vaccines, they may be eligible for a modified measles (MMR) schedule used in the trial.
GenevaAges 6 months–6 months - NCT06069492Recruiting
Wheat oral immunotherapy for children with wheat allergy
This trial tests whether a controlled, gradual treatment called oral immunotherapy can help children with wheat allergy eat wheat safely. It involves a supervised wheat challenge first, then daily wheat doses for 12 months.
Hong KongAges 1–17
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for allergy?
- Yes. Clin2 currently lists 322 recruiting allergy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a allergy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a allergy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.